Hemophilia B

Following an FDA-issued withdrawal request, an abuse-deterrent opioid will be removed from the market.

Following an FDA-issued withdrawal request, an abuse-deterrent opioid will be removed from the market.

After several studies demonstrated its efficacy, the FDA expanded the approval of the DigniCap Cooling System to prevent hair loss during chemotherapy to other cancer patients.

After several studies demonstrated its efficacy, the FDA expanded the approval of the DigniCap Cooling System to prevent hair loss during chemotherapy to other cancer patients.

After several studies demonstrated its efficacy, the FDA expanded the approval of the DigniCap Cooling System to prevent hair loss during chemotherapy to other cancer patients.

The FDA has approved a new option for the treatment of central precocious puberty.

The FDA has approved a new option for the treatment of central precocious puberty.

The FDA has approved a new option for the treatment of central precocious puberty.

The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...

The first-and-only fully human monoclonal anti-epidermal growth factor receptor antibody for the treatment of wild-type RAS metastatic colorectal cancer was recently approved by the US Food and Drug...